The Executive Director is responsible for the strategic, scientific, operational, and organizational leadership of RBIO, including but not limited to:
As an integral member of this dynamic team, you will :
• Develop and execute the long-term vision and operating strategy for RBIO, ensuring the organization evolves alongside scientific innovation, emerging therapeutic modalities, changing regulatory expectations, and business needs.
• Build future scientific, operational, and leadership capabilities that position RBIO to support increasingly complex bioanalytical and clinical development challenges.
• Partner with BAS scientific leaders to translate evolving bioanalytical strategies into scalable operational capabilities that support emerging modalities and future portfolio needs.
• Evaluate and implement innovative technologies, automation, connected data solutions, and AI-enabled scientific and operational approaches that improve operational efficiency, data integration, scientific insight, and decision-making.
• Lead organizational change initiatives that improve agility, scalability, operational excellence, and resource efficiency while maintaining the highest standards of scientific quality and regulatory compliance.
Scientific and Operational Excellence
• Provide strategic oversight for implementation and execution of regulated and exploratory bioanalysis supporting nonclinical and clinical studies across the Genentech and Roche portfolios.
• Ensure delivery of high-quality pharmacokinetic, immunogenicity, and soluble biomarker data through effective internal execution and global CRO partnerships.
• Provide leadership and oversight of bioanalytical method transfer, assay lifecycle management, clinical sample operations, technical oversight of outsourced activities, and quality reagent delivery.
• Ensure compliance with global regulatory requirements, Good Laboratory Practices (GLP), sponsor oversight expectations, internal quality systems, and applicable business processes.
• Continuously evaluate opportunities to improve scientific, operational, and business processes while maintaining excellence in execution and delivery.
External Partnerships and Enterprise Influence
• Develop and maintain strategic partnerships with global Contract Research Organizations (CROs), serving as BAS operational leader for external bioanalytical providers, shaping long-term scientific operational and innovation capabilities.
• Establish long-term outsourcing strategies that provide scientific flexibility, operational scalability, access to emerging technologies, and efficient portfolio support.
• Build strong collaborations across Research, Development Sciences, Product Development, Clinical Pharmacology, Clinical Operations, Clinical Data Management, DMPK, Quality, and other partner organizations to enable portfolio success.
• Influence enterprise scientific and operational strategies through strategic partnerships across Genentech and Roche, ensuring alignment between organizational capabilities, portfolio priorities and future business needs .
• Represent BAS on executive governance teams with external service providers and contribute to enterprise initiatives that strengthen scientific, operational, and business partnerships.
Organizational Leadership
• Lead, develop, and inspire a high-performing organization through effective coaching, succession planning, talent development, organizational design, and performance management.
• Foster an inclusive culture of scientific excellence, collaboration, continuous learning, innovation, and accountability.
• Build future leadership capability across RBIO through succession planning, mentorship, career development, strategic workforce planning, and development of future organizational leaders.
• Create an environment that encourages thoughtful evaluation of scientific and operational practices, continuous improvement, and adoption of new technologies and approaches that strengthen RBIO’s scientific and operational capabilities.
Portfolio Delivery and Governance
•Accountable for strategic workforce planning, organizational investments, budget stewardship, resource allocation and operation performance to maximize organizational effectiveness and portfolio delivery.
•Support the gRED portfolio as well as gRED-originated therapeutics across the late-stage Global Product Development portfolio.
• Partner with BAS leadership to establish departmental priorities and ensure alignment across BAS in support of the broader Development Sciences strategy.
• Partner with BAS Leadership Team to shape organizational strategy, operating models, investment priorities, scientific capabilities and long-term workforce planning for BAS.
• Support global regulatory submissions, due diligence activities, inspections, audits, portfolio integration efforts, and enterprise initiatives as required.
• Serve as a strategic scientific and operational partner to BAS and enterprise leadership to ensure delivery of high-quality bioanalytical data supporting Genentech’s innovative pipeline.